Droloxifene, a new antiestrogen: Its role in metastatic breast cancer
- 1 January 1994
- journal article
- clinical trial
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 31 (1) , 83-94
- https://doi.org/10.1007/bf00689679
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Droloxifene, a new antiestrogen, in advanced breast cancer. A double-blind dose-finding study. The Droloxifene 002 International Study Group.1991
- Droloxifene, A New Antiestrogen, in Advanced Breast CancerAmerican Journal of Clinical Oncology, 1991
- Structural Requirements for the in vitro Transformation of Syrian Hamster Embryo Cells by Stilbene Estrogens and Triphenylethylene-Type AntiestrogensAmerican Journal of Clinical Oncology, 1991
- Pharmacokinetics of Droloxifene and Its Metabolites in Breast Cancer PatientsAmerican Journal of Clinical Oncology, 1991
- Induction of Transforming Growth Factor β by the Antiestrogens Droloxifene, Tamoxifen, and Toremifene in MCF-7 CellsAmerican Journal of Clinical Oncology, 1991
- Pharmacologic and Biologic Properties of Droloxifene, A New AntiestrogenAmerican Journal of Clinical Oncology, 1991
- ANTIESTROGENIC AND ANTITUMOR EFFECTS OF DROLOXIFENE IN EXPERIMENTAL BREAST-CARCINOMA1989
- Effect of continuous vs intermittent application of 3-OH-tamoxifen or tamoxifen on the proliferation of the human breast cancer cell line MCF-7 M1Zeitschrift für Krebsforschung und Klinische Onkologie, 1989
- In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifenEuropean Journal of Cancer and Clinical Oncology, 1985
- Reporting results of cancer treatmentCancer, 1981